The treatment of red blood cell sickling disorders may involve many therapeutic modalities. Two of the most important and beneficial are treatment with hydroxyurea and chronic transfusion therapy. Hydroxyurea causes elevation of hemoglobin F (Hb F) levels, and transfusion serves to lower the percentage of hemoglobin S (Hb S). Both of these therapeutic modalities act to lessen the number and severity of sickling crises. Thus, periodic monitoring of Hb F and Hb S levels are needed to guide further therapy.
Inform your doctor if you are on any medications, have any allergies or underlying medical conditions before your Haemoglobin Variants. Your doctor will give specific instructions depending on your condition on how to prepare for Haemoglobin Variants.
Gender | Age groups | Value |
OTHER | All age groups | 95-98% |
OTHER | All age groups | 2-3% |
OTHER | All age groups | 0.8-2% |
OTHER | All age groups | Normally absent |
OTHER | All age groups | Normally absent |